Clinical Trial Update: Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating addition of Interleukin-2 to an optimized antiretroviral regimen in HIV patients with therapeutic failure. The ANRS123 study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections | Phase 2 | Status: COMPLETED